| Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques V Stoneman, D Braganza, N Figg, J Mercer, R Lang, M Goddard, ... Circulation research 100 (6), 884-893, 2007 | 345 | 2007 |
| Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher … E Yu, PA Calvert, JR Mercer, J Harrison, L Baker, NL Figg, S Kumar, ... Circulation 128 (7), 702-712, 2013 | 287 | 2013 |
| Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis I Gorenne, S Kumar, K Gray, N Figg, H Yu, J Mercer, M Bennett Circulation 127 (3), 386-396, 2013 | 285 | 2013 |
| DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome JR Mercer, KK Cheng, N Figg, I Gorenne, M Mahmoudi, J Griffin, ... Circulation research 107 (8), 1021-1031, 2010 | 277 | 2010 |
| The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/–/ApoE–/–mice JR Mercer, E Yu, N Figg, KK Cheng, TA Prime, JL Griffin, M Masoodi, ... Free Radical Biology and Medicine 52 (5), 841-849, 2012 | 207 | 2012 |
| Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice J Mercer, N Figg, V Stoneman, D Braganza, MR Bennett Circulation research 96 (6), 667-674, 2005 | 204 | 2005 |
| DNA damage and repair in atherosclerosis M Mahmoudi, J Mercer, M Bennett Cardiovascular research 71 (2), 259-268, 2006 | 178 | 2006 |
| Mitochondria in vascular disease E Yu, J Mercer, M Bennett Cardiovascular research 95 (2), 173-182, 2012 | 177 | 2012 |
| Statins use a novel Nijmegen breakage syndrome-1–dependent pathway to accelerate DNA repair in vascular smooth muscle cells M Mahmoudi, I Gorenne, J Mercer, N Figg, T Littlewood, M Bennett Circulation research 103 (7), 717-725, 2008 | 156 | 2008 |
| DNA damage, p53, apoptosis and vascular disease J Mercer, M Mahmoudi, M Bennett Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 621 (1 …, 2007 | 137 | 2007 |
| Effects of DNA damage in smooth muscle cells in atherosclerosis K Gray, S Kumar, N Figg, J Harrison, L Baker, J Mercer, T Littlewood, ... Circulation research 116 (5), 816-826, 2015 | 110 | 2015 |
| The role of p53 in atherosclerosis J Mercer, M Bennett Cell cycle 5 (17), 1907-1909, 2006 | 100 | 2006 |
| The future of cardiovascular stents: bioresorbable and integrated biosensor technology D Hoare, A Bussooa, S Neale, N Mirzai, J Mercer Advanced Science 6 (20), 1900856, 2019 | 82 | 2019 |
| Battery‐free and wireless technologies for cardiovascular implantable medical devices J Zhang, R Das, J Zhao, N Mirzai, J Mercer, H Heidari Advanced Materials Technologies 7 (6), 2101086, 2022 | 68 | 2022 |
| Impaired mitochondrial respiration in human carotid plaque atherosclerosis: A potential role for Pink1 in vascular smooth muscle cell energetics CK Docherty, A Carswell, E Friel, JR Mercer Atherosclerosis 268, 1-11, 2018 | 60 | 2018 |
| Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment MM Kavurma, N Figg, MR Bennett, J Mercer, LM Khachigian, ... Biochemical Journal 407 (1), 79-87, 2007 | 55 | 2007 |
| Extracellular vesicle signalling in atherosclerosis E Charla, J Mercer, P Maffia, SA Nicklin Cellular signalling 75, 109751, 2020 | 50 | 2020 |
| Future of smart cardiovascular implants A Bussooa, S Neale, JR Mercer Sensors 18 (7), 2008, 2018 | 50 | 2018 |
| How does juxtaluminal calcium affect critical mechanical conditions in carotid atherosclerotic plaque? An exploratory study Z Teng, J He, U Sadat, JR Mercer, X Wang, NS Bahaei, OM Thomas, ... IEEE Transactions on Biomedical Engineering 61 (1), 35-40, 2013 | 39 | 2013 |
| Mitochondrial bioenergetics and therapeutic intervention in cardiovascular disease JR Mercer Pharmacology & therapeutics 141 (1), 13-20, 2014 | 32 | 2014 |